[
    "{\"step_by_step_thinking\": \"Based on the information provided in the documents, durvalumab is indeed used for lung cancer treatment. Document [0] discusses the use of durvalumab as a potential maintenance therapy in surgery-ineligible non-small-cell lung cancer. Document [1] specifically mentions the efficacy of durvalumab in the treatment of stage III non-small cell lung cancer. Document [3] states that durvalumab is approved by the US Food and Drug Administration for use in adults with unresectable, Stage III non-small cell lung cancer. Additionally, Document [6] mentions the PACIFIC trial, which demonstrated significant improvements in progression-free survival and overall survival in patients with unresectable, stage III NSCLC who received durvalumab after chemoradiotherapy. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]